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Reviewing Jim Watson’s The Double Helix, 
Erwin Chargaff dismissed scientific auto-
biography as “a most awkward literary genre”, 
arguing that most scientists lead monotonous 
and uneventful lives. This certainly does not 
apply to Craig Venter, whose autobiography 
is fittingly well-written, fast-paced and full of 
interesting data, gossip — and score-settling. 
Little introduction is necessary for the man 
who is possibly the celebrity scientist of the mod-
ern era. Venter’s name has rarely been out of the 
headlines for the past 12 years. Most recently, on 
the publication of his own genome sequence, his 
portrait occupied one-third of the front page of 
the New York Times’s science section. His fame 
peaked at the beginning of the millennium at the 
celebrations for the first release of the human-
genome sequence. Inspired by Darwin’s Beagle 
voyage, he then set sail in his yacht Sorcerer II to 
catalogue the oceans’ bacteria and viruses.
Close encounter
A Life Decoded is in three parts, divided by two 
epiphanies. Venter grew up a bad boy in Mill-
brae near San Francisco. On his bike he raced 
planes taking off from the airport, and hung 
out with other bad boys. Many character traits 
formed early, notably the competitive — and 
combative — spirit: his track relay team set a 
US record and his swimming coach thought 
him to be potential Olympic material. His love 
of sailing began when he built a hydroplane to 
plans in Popular Mechanics. That Venter gradu-
ated was a close-run thing: his grades were poor 
and he led a school sit-in to protest against a 
teacher’s dismissal. At 17, he set off to southern 
California for surfing, girls and drink.
In late 1960s America, the good times couldn’t 
last for a healthy young man. The armed forces 
beckoned and Venter enlisted in the hospital 
corps. His talent for spinal taps kept his name 
off the lists of postings to Vietnam. But he was 
eventually shipped off to a hospital in Da Nang. 
Experiences of working with the wounded and 
dying left a lifelong mark on Venter, of which 
he writes with candour and passion. 
Epiphany number one came after 5 months 
in Vietnam. He decided to commit suicide by 
swimming out to sea. Out of sight of land, a 
nudge from a shark made him race back. He 
served out his time in Vietnam and returned to 
California in late 1968, marrying his girlfriend 
and buying a motorbike en route.
Venter quickly made up for his misspent 
youth, enrolling first in a community col-
lege, then moving to the University of Cali-
fornia, San Diego. He studied biochemistry 
and researched into the action of adrenaline. 
Publishing his work proved more satisfying 
than winning swimming or sailing competi-
tions. After graduation, Venter continued with 
research on hormones and their receptors, 
completing his doctoral thesis in 1975. Follow-
ing a productive period at the State University 
of New York, Buffalo, where his son was born, 
he divorced his wife and married Claire Fraser, 
now director of the Institute for Genome Sci-
ences at the University of Maryland School of 
Medicine in Baltimore. In 1984, he and Fraser 
moved to the National Institute of Neurological 
Disorders and Stroke (NINDS) in Bethesda, 
Maryland, and continued to work on neuro-
transmitter receptors.
Epiphany number two came in 1987. Ven-
ter read a paper from Lee Hood’s laboratory at 
the California Institute of Technology on the 
automation of DNA sequencing. After months 
of toil to clone and sequence the human brain 
β-adrenergic receptor, the idea that a machine 
could replace postdocs and technicians was 
thrilling. He phoned Mike Hunkapiller, 
who developed the automated sequencers at 
CalTech, and ordered a machine. In a prophetic 
turn of events, he paid for it with his rainy-day 
savings when his NINDS boss allegedly refused 
to fund it. Within a few months, Venter and his 
colleagues had sequenced two receptors. 
It was about this time that I met Venter at a 
conference on new developments in complex 
human genetic disorders, where he displayed 
his characteristic impatience with those who 
play it safe. One participant remarked that 
what would most help her research would be 
the sequence of the 300-kilobase region she 
was studying. Venter said, in effect, why don’t 
you just get on and do it then? His suggestion 
was regarded with incredulity.
Genome giant
The larger part of A Life Decoded chronicles 
Venter’s controversial move into genomics and 
his part in sequencing the human genome. He 
covers a lot of ground, with facts, quotations 
and accounts of others’ intentions. Some asser-
tions lack references, so the reader must take 
them on trust. Venter pillories a long list of 
people whom he believes conspired and lied 
to obstruct him, but offers generous praise for 
the staff of his institutes who tackled obstacles 
not of their making.
Clashes began while Venter was at the 
National Institutes of Health (NIH) in the 
early nineties, over sequence patenting and 
strategies for cracking whole genomes. Even-
tually, Venter left and set up The Institute for 
Genomic Research in Rockville, Maryland. His 
team used whole-genome assembly (WGA) to 
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sequence the Haemophilus influenzae genome, 
which was eight times larger than the previ-
ous record. Instead of painstakingly cloning, 
mapping the clones and sequencing them, 
they blasted H. influenzae DNA into frag-
ments, sequenced these, and used a computer 
to assemble the complete genome that graced 
the cover of Science on 28 July 1995. WGA 
became standard procedure for microbes: 
Mycoplasma genitalium, Methanococcus 
jannaschii and many more quickly followed. 
By 1998, the Human Genome Project, 
financed by the NIH and the US Department 
of Energy (DoE), was making slow and steady 
progress by mapping clones, sequencing them 
and using the map to assemble the genome. In 
May of that year, everything changed. Venter 
announced that he and Hunkapiller (by now 
running Applied Biosystems) were forming 
a private company, Celera, to sequence the 
human genome more cheaply and faster than 
the non-commercially funded consortium, 
later called the International Human Genome 
Sequencing Consortium. They would use 
WGA and capillary sequencers not yet built.
The announcement, covered by the world’s 
press, was met with incredulity (WGA would 
never work with a genome so complex), con-
sternation (the human genome would be in the 
hands of a private company) and fear (would 
Congress and the Wellcome Trust cut off fund-
ing for the public project?). Days later at the 
Cold Spring Harbor Laboratory Genome Map-
ping and Sequencing meeting on Long Island, 
New York, the tension was palpable — and 
exciting. With characteristic chutzpah, Venter 
fanned the sparks when he suggested that the 
NIH and DoE teams give up on the human 
genome and do the mouse instead. 
Jim Watson was at the meeting, asking the 
elite how they were to counter-attack. It was 
not the US cavalry but the British Grenadiers 
— John Sulston and Michael Morgan of the 
Wellcome Trust — who restored confidence. 
The public effort girded its loins and stepped 
up the pace. Interactions between public and 
private projects remained poisonous. Occa-
sional attempts at reconciliation foundered on 
data-release issues. 
Only three years later, first drafts of the 
human genome were published simultaneously 
by Celera and the public consortium. Venter 
shared a podium with Francis Collins, head of 
the US genome project, and President Bill Clin-
ton at the White House, while UK Prime Min-
ister Tony Blair attended via satellite link. Even 
this moment of triumph held no reconciliation. 
Venter balked at the standard requirement that 
all data should be provided in the paper, so Cel-
era published in Science, as it had agreed, with 
restricted access. The public group, making 
all their sequence available for free, published 
in Nature. Squabbling continued over exactly 
how the private sequence had been assembled. 
Many people’s worst opinions of Venter were 
confirmed when he admitted that most of the 
Celera sequence was his own, rather than that of 
anonymous DNA donors. One journalist called 
it a “high point in the annals of egotism”. 
Called to account
This year, Venter and Watson became the first 
people to have their entire genomes sequenced 
and made public. Both believe that decipher-
ing our individual genetic inheritance will 
lead to better health: if there are no therapies 
yet for what is found, the risk might be mini-
mized. Venter underlines the point throughout 
his book by describing what particular genes 
mean for him. For example, he takes a statin 
to lower his cholesterol levels, because he has 
the E4 allele of the APOE gene that increases 
the risk of Alzheimer’s disease. 
I have interacted with Venter over the years 
since our first meeting in 1990, and have heard 
many strong opinions of his character. A Life 
Decoded is a fair representation of the man. It 
may even be more revealing than he thinks. 
But the differing published accounts of the 
Drosophila and human-genome sequencing 
projects are reminiscent of the fable about 
the blind men who described an elephant by 
touch. Reading the books by John Sulston 
and Georgina Ferry (The Common Thread: A 
Story of Science, Politics, Ethics and the Human 
Genome), James Shreeve (The Genome War: 
How Craig Venter Tried to Capture the Code of 
Life and Save the World), Michael Ashburner 
(Won for All: How the Drosophila Genome 
Was Sequenced) and now Venter’s contribu-
tion, it is scarcely credible that the protagonists 
lived through the same events. Robert Cook-
Deegan’s The Gene Wars: Science, Politics, and 
the Human Genome provided an authoritative, 
inside-the-Beltway account of the early days 
of the Human Genome Project, but what we 
need is a record of the whole project by a team 
of historians with no axe to grind. 
Such an endeavour should begin with a 
comprehensive collection of material, along 
the lines of Thomas Kuhn’s Sources for History 
of Quantum Physics. Kuhn and his colleagues 
interviewed the participants in, and found pri-
mary documents relating to, the greatest change 
in our view of the physical world since Isaac 
Newton. The greatest project in biology so far 
deserves to be similarly documented. The prin-
cipals are still with us, as are their e-mails.
Chargaff called the heroes of The Double 
Helix “a new kind of scientist, one that could 
hardly have been thought of before science 
became a mass occupation, subject to, and 
forming part of, all the vulgarities of the com-
munications media”. Four decades on, our 
infinitely more vulgar media has called Ven-
ter many things: maverick, publicity hound, 
risk-taker, brash, controversial, genius, manic, 
rebellious, visionary, audacious, arrogant, 
feisty, determined, provocative. His autobiog-
raphy shows that they are all justified. ■
Jan Witkowski is director of the Banbury Center, 
New York, and professor in the Watson School 
of Biological Sciences at Cold Spring Harbor 
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German biologist Ernst Haeckel branded radiolarians — tiny seawater plankton 
— one of the “art forms of nature”, an accolade borne out under the scrutiny 
of the scanning electron microscope almost a century later. These single-
celled animals come in a variety of intricate shapes, as shown in this image of a 
radiolarian shell. It is one from a striking collection of micrographs assembled 
by the Science Photo Library for Microcosmos by Brandon Broll (Firefly 
Books, 2007).
The book includes some 200 images, taken at up to 22 million times 
magnification, of subjects drawn from biology, mineralogy and technology. 
Readers can marvel at pictures of a hummingbird hawkmoth’s tongue and of 
nanowires just ten atoms wide, of exotic gallstone crystals, butterfly scales and 
hairy gecko feet. Although kettle scale and a wound dressing in filigree may be 
a step too far into the microcosmos, there is wonder lurking in these too.
The micrographs are showcased with cunning digital artistry to impart colour. 
In places this borders on the fanciful (garish crystals of vitamin C and a Siberian 
microdiamond), but otherwise brings the pictures sharply to life. 
A gallery of micrographs
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